|
MEDAREX INC.
Medarex, Inc. (MEDX) is a biopharmaceutical company that we believe represents a unique, risk-reduced biotechnology investment opportunity. MEDX has a proprietary human antibody services business based on its HuMAb-Mouse system, seven antibody-based products currently in clinical trials, a long list of major corporate partners (with the potential for many additional collaborations), and a strong financial position. We are initiating coverage of MEDX will a BUY rating. SMALLCAPS RESEARCH Initial Opinion (HTML) (05/18/99) |